Literature DB >> 27730304

[Gouty arthritis].

A-K Tausche1, M Aringer2.   

Abstract

Gouty arthritis is the most common form of arthritis in men. As a consequence of persisting hyperuricemia, uric acid crystals are deposited in the intra-articular and periarticular spaces and activate the innate immune system. The clinically impressive abrupt onset monoarticular arthritis in the lower extremities is highly suggestive of a gout attack. Arthrosonography can be used for early detection of crystal deposition on joint cartilage. In synovial fluid the detection of uric acid crystals in polarization microscopy is proof of gout even without the detection of intracellular uric acid crystals. Rapidly acting anti-inflammatory drugs are available for acute treatment of attacks; however, the essential therapy is the effective and life-long drug treatment of hyperuricemia from the first attack onwards, typically with allopurinol or febuxostat. This review delineates the clinically relevant knowledge on the pathogenesis, diagnosis and therapy of gout based on the currently available evidence.

Entities:  

Keywords:  Arthritis; Crystal arthropathy; Hyperuricemia; Joint; Uric acid

Mesh:

Substances:

Year:  2016        PMID: 27730304     DOI: 10.1007/s00393-016-0206-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  28 in total

1.  [Gout].

Authors:  N ZOLLNER
Journal:  Dtsch Med Wochenschr       Date:  1959-05-08       Impact factor: 0.628

2.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

3.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  Nocturnal risk of gout attacks.

Authors:  Hyon K Choi; Jingbo Niu; Tuhina Neogi; Clara A Chen; Christine Chaisson; David Hunter; Yuqing Zhang
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

5.  A 3-day delay in synovial fluid crystal identification did not hinder the reliable detection of monosodium urate and calcium pyrophosphate crystals.

Authors:  Anne-Kathrin Tausche; Siegmund Gehrisch; Ines Panzner; Maria Winzer; Ursula Range; Stefan R Bornstein; Gabriele Siegert; Carsten Wunderlich; Martin Aringer
Journal:  J Clin Rheumatol       Date:  2013-08       Impact factor: 3.517

6.  Monosodium urate crystals in the knee joints of patients with asymptomatic nontophaceous gout.

Authors:  J S Bomalaski; G Lluberas; H R Schumacher
Journal:  Arthritis Rheum       Date:  1986-12

7.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

8.  Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.

Authors:  Puja P Khanna; George Nuki; Thomas Bardin; Anne-Kathrin Tausche; Anna Forsythe; Amir Goren; Jeffrey Vietri; Dinesh Khanna
Journal:  Health Qual Life Outcomes       Date:  2012-09-22       Impact factor: 3.186

9.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

10.  Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Authors:  L Annemans; E Spaepen; M Gaskin; M Bonnemaire; V Malier; T Gilbert; G Nuki
Journal:  Ann Rheum Dis       Date:  2007-11-02       Impact factor: 19.103

View more
  2 in total

1.  Simiaosan alleviates the symptoms of gouty arthritis via the NALP3/IL‑1β pathway.

Authors:  Xianzhen Zhang; Huideng Ding; Gang Hu; Ying Lu
Journal:  Mol Med Rep       Date:  2021-01-24       Impact factor: 2.952

2.  Sepsis complicated with secondary hemophagocytic syndrome induced by giant gouty tophi rupture: A case report.

Authors:  Bin Lai; Zhi-Hui Pang
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.